|
|
|
Volumn 28, Issue 4, 1996, Pages 2196-2198
|
|
Conversion from sandimmune to neoral in stable renal transplant recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG SAFETY;
DYSPEPSIA;
EMULSION;
FEMALE;
GRAFT REJECTION;
HEADACHE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VOMITING;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CYCLOSPORINE;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
TIME FACTORS;
|
|
EID: 0029840388
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
